Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
  • The Cook Central Office, 36 South Wabash Avenue, Chicago, will close 02/03/2025.  The new Cook Central Office will open at 115 South LaSalle, Chicago, for in-person service on 02/10/2025.  
  • UPDATE: The State Disbursement Unit (SDU) is processing all payments received. To verify the status of your payment, please log into the SDU parent portal or contact the SDU Customer Service Call Center at 877.225.7077.  For SDU business hours, click here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 15, 2016

Drug Name

Review Type

Class

Manufacturer

Dyanavel XR Susp.
New Drug Initial Review
Stimulants
Tris Pharma, Inc.
Viberzi
New Drug Initial Review
Irritable Bowel with diarrhea
Allergan
Xeljanz
New Drug Appeal
Rheumatoid Arthritis
Pfizer
Xeljanz XR
New Drug Appeal
Rheumatoid Arthritis
Pfizer
Savaysa
New Drug Appeal
NOAC Anti-Coagulant
Daiichi Sankyo
Orenitram
New Drug Appeal
Pulmonary Arterial Hypertension
United Therapeutics
Brilinta
PDL Appeal
Platelet Aggregation Inhibitor
AstraZeneca